MicroRNAs in the Pathobiology of Multiple Myeloma

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|7|823-837

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.7, 2012-09, pp. : 823-837

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment

By  

Current Cancer Drug Targets, Vol. 17, Iss. 9, 2017-10 ,pp. : 819-838

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs in Colorectal Neoplasia: From Pathobiology to Clinical Applications

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 468-474

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: [Hot Topic: New Approaches in the Treatment of Multiple Myeloma: From Target-based Agents to the New Era of microRNAs (Dedicated to the Memory of Prof. Salvatore Venuta)]

By  

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-01 ,pp. : 741-742

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs and multiple sclerosis: from physiopathology toward therapy

By Zare-Shahabadi Ameneh   Renaudineau Yves   Rezaei Nima  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1497-1507

Informa Healthcare

Access to resources Recommend Favorite

The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 2, 2015-03 ,pp. : 157-167

Bentham Science Publishers

Access to resources Recommend Favorite